The secondary endpoints were time from randomization to first hospitalization due to acute decompensated HF and/or death; cumulative incidence of hospitalization due to decompensated HF, death or both; changes in NYHA class throughout follow-ups; NT-proBNP changes before and after treatment; quality of life (QoL) assessment throughout the follow-ups. Here, NPPB is linked to hydrops fetalis.